|
1
|
Schrijver WAME, Schuurman K and van Rossum
A: Dutch Distant Breast Cancer Metastases Consortium, Peeters T,
Ter Hoeve N, Zwart W, van Diest PJ and Moelans CB: Loss of steroid
hormone receptors is common in malignant pleural and peritoneal
effusions of breast cancer patients treated with endocrine therapy.
Oncotarget. 8:55550–55561. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Zeidan AM, Long JB, Wang R, Hu X, Yu JB,
Huntington SF, Abel GA, Mougalian SS, Podoltsev NA, Gore SD, et al:
Risk of myeloid neoplasms after radiotherapy among older women with
localized breast cancer: A population-based study. PLoS One.
12:e01847472017. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Ahn JO, Lee HW, Seo KW, Kang SK, Ra JC and
Youn HY: Anti-tumor effect of adipose tissue derived-mesenchymal
stem cells expressing interferon-β and treatment with cisplatin in
a xenograft mouse model for canine melanoma. PLoS One.
8:e748972013. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Ryu H, Oh JE, Rhee KJ, Baik SK, Kim J,
Kang SJ, Sohn JH, Choi E, Shin HC, Kim YM, et al: Adipose
tissue-derived mesenchymal stem cells cultured at high density
express IFN-β and suppress the growth of MCF-7 human breast cancer
cells. Cancer Lett. 352:220–227. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Lee DH, Ahn Y, Kim SU, Wang KC, Cho BK,
Phi JH, Park IH, Black PM, Carroll RS, Lee J and Kim SK: Targeting
rat brainstem glioma using human neural stem cells and human
mesenchymal stem cells. Clin Cancer Res. 15:4925–4934. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Knoop K, Schwenk N, Dolp P, Willhauck MJ,
Zischek C, Zach C, Hacker M, Göke B, Wagner E, Nelson PJ and
Spitzweg C: Stromal targeting of sodium iodide symporter using
mesenchymal stem cells allows enhanced imaging and therapy of
hepatocellular carcinoma. Hum Gene Ther. 24:306–316. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Payne NL, Sun G, McDonald C, Layton D,
Moussa L, Emerson-Webber A, Veron N, Siatskas C, Herszfeld D, Price
J and Bernard CC: Distinct immunomodulatory and migratory
mechanisms underpin the therapeutic potential of human mesenchymal
stem cells in autoimmune demyelination. Cell Transplant.
22:1409–1425. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Molloy AP, Martin FT, Dwyer RM, Griffin
TP, Murphy M, Barry FP, O'Brien T and Kerin MJ: Mesenchymal stem
cell secretion of chemokines during differentiation into
osteoblasts, and their potential role in mediating interactions
with breast cancer cells. Int J Cancer. 124:326–332. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Dwyer RM, Potter-Beirne SM, Harrington KA,
Lowery AJ, Hennessy E, Murphy JM, Barry FP, O'Brien T and Kerin MJ:
Monocyte chemotactic protein-1 secreted by primary breast tumors
stimulates migration of mesenchymal stem cells. Clin Cancer Res.
13:5020–5027. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Macho-Fernandez E, Cruz LJ, Ghinnagow R,
Fontaine J, Bialecki E, Frisch B, Trottein F and Faveeuw C:
Targeted delivery of α-galactosylceramide to CD8α+ dendritic cells
optimizes type I NKT cell-based antitumor responses. J Immunol.
193:961–969. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Keyhani A, Riazi-Rad F, Pakzad SR and
Ajdary S: Human polymorphonuclear leukocytes produce cytokines in
response to Leishmania major promastigotes. APMIS. 122:891–897.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Sun H, Sun C and Xiao W: Expression
regulation of co-inhibitory molecules on human natural killer cells
in response to cytokine stimulations. Cytokine. 65:33–41. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Lim HX, Hong HJ, Cho D and Kim TS: IL-18
enhances immunosuppressive responses by promoting differentiation
into monocytic myeloid-derived suppressor cells. J Immunol.
193:5453–5460. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Jarry A, Malard F, Bou-Hanna C, Meurette
G, Mohty M, Mosnier JF, Laboisse CL and Bossard C: Interferon-alpha
promotes Th1 response and epithelial apoptosis via inflammasome
activation in human intestinal mucosa. Cell Mol Gastroenterol
Hepatol. 3:72–81. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Serti E, Werner JM, Chattergoon M, Cox AL,
Lohmann V and Rehermann B: Monocytes activate natural killer cells
via inflammasome-induced interleukin 18 in response to hepatitis C
virus replication. Gastroenterology. 147:209–220.e3. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Nakata A, Tsujimura T, Sugihara A, Okamura
H, Iwasaki T, Shinkai K, Iwata N, Kakishita E, Akedo H and Terada
N: Inhibition by interleukin 18 of osteolytic bone metastasis by
human breast cancer cells. Anticancer Res. 19:4131–4138.
1999.PubMed/NCBI
|
|
17
|
Coskun U, Gunel N, Sancak B, Onuk E,
Bayram M and Cihan A: Effect of tamoxifen on serum IL-18, vascular
endothelial growth factor and nitric oxide activities in breast
carcinoma patients. Clin Exp Immunol. 137:546–551. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Ye ZB, Ma T, Li H, Jin XL and Xu HM:
Expression and significance of intratumoral interleukin-12 and
interleukin-18 in human gastric carcinoma. World J Gastroenterol.
13:1747–1751. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Liu X, Hu J, Sun S, Li F, Cao W, Wang YU,
Ma Z and Yu Z: Mesenchymal stem cells expressing interleukin-18
suppress breast cancer cells in vitro. Exp Ther Med. 9:1192–1200.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Doucette T, Rao G, Yang Y, Gumin J,
Shinojima N, Bekele BN, Qiao W, Zhang W and Lang FF: Mesenchymal
stem cells display tumor-specific tropism in an RCAS/Ntv-a glioma
model. Neoplasia. 13:716–725. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Sage EK, Kolluri KK, McNulty K, Lourenco
Sda S, Kalber TL, Ordidge KL, Davies D, Lee Gary YC, Giangreco A
and Janes SM: Systemic but not topical TRAIL-expressing mesenchymal
stem cells reduce tumour growth in malignant mesothelioma. Thorax.
69:638–647. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Esposito M and Kang Y: Targeting
tumor-stromal interactions in bone metastasis. Pharmacol Ther.
141:222–233. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Moniri MR, Sun XY, Rayat J, Dai D, Ao Z,
He Z, Verchere CB, Dai LJ and Warnock GL: TRAIL-engineered
pancreas-derived mesenchymal stem cells: Characterization and
cytotoxic effects on pancreatic cancer cells. Cancer Gene Ther.
19:652–658. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Müller J, Feige K, Wunderlin P, Hödl A,
Meli ML, Seltenhammer M, Grest P, Nicolson L, Schelling C and
Heinzerling LM: Double-blind placebo-controlled study with
interleukin-18 and interleukin-12-encoding plasmid DNA shows
antitumor effect in metastatic melanoma in gray horses. J
Immunother. 34:58–64. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Choi IK, Lee JS, Zhang SN, Park J, Sonn
CH, Lee KM and Yun CO: Oncolytic adenovirus co-expressing IL-12 and
IL-18 improves tumor-specific immunity via differentiation of T
cells expressing IL-12Rβ2 or IL-18Rα. Gene Ther. 18:898–909. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Yang J, Jin G, Liu X and Liu S:
Therapeutic effect of pEgr-IL18-B7.2 gene radiotherapy in B16
melanoma-bearing mice. Hum Gene Ther. 18:323–332. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Galon J, Costes A, Sanchez-Cabo F,
Kirilovsky A, Mlecnik B, Lagorce-Pagès C, Tosolini M, Camus M,
Berger A, Wind P, et al: Type, density, and location of immune
cells within human colorectal tumors predict clinical outcome.
Science. 313:1960–1964. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Sato E, Olson SH, Ahn J, Bundy B,
Nishikawa H, Qian F, Jungbluth AA, Frosina D, Gnjatic S, Ambrosone
C, et al: Intraepithelial CD8 tumor-infiltrating lymphocytes and a
high CD8t/regulatory T cell ratio are associated with favorable
prognosis in ovarian cancer. Proc Natl Acad Sci USA.
102:18538–18543. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Rodrigues DR, Fernandes RK, Balderramas
Hde A, Penitenti M, Bachiega TF, Calvi SA, Dias-Melicio LA, Ikoma
MR and Soares ÂM: Interferon-gamma production by human neutrophils
upon stimulation by IL-12, IL-15 and IL-18 and challenge with
Paracoccidioides brasiliensis. Cytokine. 69:102–109. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Ruiz C, Pérez E, García-Martínez O,
Díaz-Rodríguez L, Arroyo-Morales M and Reyes-Botella C: Expression
of cytokines IL-4, IL-12, IL-15, IL-18, and IFNgamma and modulation
by different growth factors in cultured human osteoblast-like
cells. J Bone Miner Metab. 25:286–292. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Mailliard RB, Alber SM, Shen H, Watkins
SC, Kirkwood JM, Herberman RB and Kalinski P: IL-18-induced CD83+
CCR7+ NK helper cells. J Exp Med. 202:941–953. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Mailliard RB, Son YI, Redlinger R, Coates
PT, Giermasz A, Morel PA, Storkus WJ and Kalinski P: Dendritic
cells mediate NK cell help for Th1 and CTL responses: Two-signal
requirement for the induction of NK cell helper function. J
Immunol. 171:2366–2373. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Wong JL, Muthuswamy R, Bartlett DL and
Kalinski P: IL-18-based combinatorial adjuvants promote the
intranodal production of CCL19 by NK cells and dendritic cells of
cancer patients. Oncoimmunology. 2:e262452013. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Zhong L, Roybal J, Chaerkady R, Zhang W,
Choi K, Alvarez CA, Tran H, Creighton CJ, Yan S, Strieter RM, et
al: Identification of secreted proteins that mediate cell-cell
interactions in an in vitro model of the lung cancer
microenvironment. Cancer Res. 68:7237–7245. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Ribatti D, Belloni AS, Nico B, Di Comite
M, Crivellato E and Vacca A: Leptin-leptin receptor are involved in
angiogenesis in human hepatocellular carcinoma. Peptides.
29:1596–1602. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Gray-Schopfer V, Wellbrock C and Marais R:
Melanoma biology and new targeted therapy. Nature. 445:851–857.
2007. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Yamada N, Hata M, Ohyama H, Yamanegi K,
Kogoe N, Nakasho K, Futani H, Okamura H and Terada N: Immunotherapy
with interleukin-18 in combination with preoperative chemotherapy
with ifosfamide effectively inhibits postoperative progression of
pulmonary metastases in a mouse osteosarcoma model. Tumour Biol.
30:176–184. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Pappa CA, Alexandrakis MG, Boula A,
Psarakis FE, Kolovou A, Bantouna V, Stavroulaki E and Tsirakis G:
Emerging roles of endoglin/CD105 and angiogenic cytokines for
disease development and progression in multiple myeloma patients.
Hematol Oncol. 31:201–205. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Dwivedi S, Goel A, Natu SM, Mandhani A,
Khattri S and Pant KK: Diagnostic and prognostic significance of
prostate specific antigen and serum interleukin 18 and 10 in
patients with locally advanced prostate cancer: A prospective
study. Asian Pac J Cancer Prev. 12:1843–1848. 2011.PubMed/NCBI
|
|
40
|
Goto N, Tsurumi H, Kasahara S, Kanemura N,
Hara T, Yasuda I, Shimizu M, Murakami N, Sawada M, Yamada T, et al:
Serum interleukin-18 level is associated with the outcome of
patients with diffuse large B-cell lymphoma treated with CHOP or
R-CHOP regimens. Eur J Haematol. 87:217–227. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Vidal-Vanaclocha F, Mendoza L, Telleria N,
Salado C, Valcárcel M, Gallot N, Carrascal T, Egilegor E,
Beaskoetxea J and Dinarello CA: Clinical and experimental
approaches to the pathophysiology of interleukin-18 in cancer
progression. Cancer Metastasis Rev. 25:417–434. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Terme M, Ullrich E, Aymeric L, Meinhardt
K, Desbois M, Delahaye N, Viaud S, Ryffel B, Yagita H, Kaplanski G,
et al: IL-18 induces PD-1-dependent immunosuppression in cancer.
Cancer Res. 71:5393–5399. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Terme M, Ullrich E, Aymeric L, Meinhardt
K, Coudert JD, Desbois M, Ghiringhelli F, Viaud S, Ryffel B, Yagita
H, et al: Cancer-induced immunosuppression: IL-18-elicited
immunoablative NK cells. Cancer Res. 72:2757–2767. 2012. View Article : Google Scholar : PubMed/NCBI
|
